{"nctId":"NCT05027048","briefTitle":"Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery","startDateStruct":{"date":"2022-04-04","type":"ACTUAL"},"conditions":["Uterine Atony","Uterine Atony With Hemorrhage","Postpartum Hemorrhage","Cesarean Section Complications"],"count":120,"armGroups":[{"label":"Calcium chloride","type":"EXPERIMENTAL","interventionNames":["Drug: Calcium chloride"]},{"label":"Saline placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Saline placebo"]}],"interventions":[{"name":"Calcium chloride","otherNames":[]},{"name":"Saline placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient had a trial of labor for vaginal delivery prior to cesarean\n* Patient received an oxytocin infusion for labor augmentation or induction prior to cesarean\n\nExclusion Criteria:\n\n* renal dysfunction with serum Cr \\>1.0 mg/dL\n* known underlying cardiac condition\n* treatment with digoxin within the last 2 weeks for a maternal or fetal indication\n* treatment with a calcium channel blocker medication within 24 hours\n* hypertension necessitating intravenous antihypertensive medication within 24 hours\n* emergent case in which study participation could in any way impede patient care by the judgement of the obstetrician, anesthesiologist, or bedside nurse","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"55 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Quantitative Blood Loss","description":"Standardized volumetric and gravimetric assessment of blood loss during cesarean. Note: will analyze all participants, but planned subgroup analysis will also occur excluding patients with non-atonic reasons for blood loss including hysterotomy extension, placental abruption, cervical or vaginal laceration, etc","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"840","spread":null},{"groupId":"OG001","value":"1051","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Postpartum Hemorrhage","description":"Postpartum hemorrhage was defined as quantitative blood loss \\> 1000 milliliters during operative course","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"34","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Second Line Uterotonic Requirement","description":"Yes/no: did the patient require treatment with methylergonovine, carboprost, and/or misoprostol for uterine atony","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"24","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With a Transfusion Requirement","description":"Yes/no, if patient required transfusion of packed red blood cells prior to hospital discharge","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Hematocrit From Baseline","description":"Measured pre-delivery hematocrit minus measured post-operative day 1 hematocrit. Correction factor of 3 hematocrit points per unit packed red blood cells transfused","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.8","spread":null},{"groupId":"OG001","value":"9.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Oxytocin Bolus Requirement","description":"Total dose oxytocin bolus during cesarean","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Uterine Tone Numerical Rating Score, 7 Minutes After Fetal Delivery","description":"Uterine tone assessment: Obstetricians at the study institution use the following validated scale to grade uterine tone for all cesarean deliveries. The obstetrician places their hand directly on the uterine fundus and scores the adequacy of contraction. The interrater characteristics of this scale have been published (Cole et al, 2021).\n\nThe scale ranges from 0-10. A score of 0 is the worst possible score and represents a flaccid, atonic uterus. A score of 10 is the best possible score and represents a firmly-contracted uterus.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"6.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Uterine Tone Numerical Rating Score, 12 Minutes After Fetal Delivery","description":"Uterine tone assessment: Obstetricians at the study institution use the following validated scale to grade uterine tone for all cesarean deliveries. The obstetrician places their hand directly on the uterine fundus and scores the adequacy of contraction. The interrater characteristics of this scale have been published (Cole et al, PMID 33652161).\n\nThe scale ranges from 0-10. A score of 0 is the worst possible score and represents a flaccid, atonic uterus. A score of 10 is the best possible score and represents a firmly-contracted uterus.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Fluid Requirement","description":"Total crystalloid required during cesarean delivery in mL","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1594","spread":"762"},{"groupId":"OG001","value":"1502","spread":"892"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Mean Arterial Pressure","description":"Baseline mean arterial blood pressure recorded as average of first 6 mean arterial blood pressures recorded in operating room. Percent change calculated as measured mean arterial blood pressure minus baseline, divided by baseline. Reported here as the maximal decrease in mean arterial pressure. Repeated measures ANOVA reported in Statistical Analysis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change in Heart Rate From Baseline","description":"Baseline heart rate recorded as average of first 6 heart rates recorded in operating room. Percent change calculated as measured heart rate minus baseline, divided by baseline. Maximal % increase in heart rate reported here. Repeated measures ANOVA used to analyze overall trend in Statistical Analysis below.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Phenylephrine Requirement","description":"Total phenylephrine in milligrams administered while in the operating room","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.02","spread":null},{"groupId":"OG001","value":"1.09","spread":null}]}]}]},{"type":"SECONDARY","title":"Pharmacokinetics of Calcium Chloride - Baseline Ionized Calcium","description":"Measured using an Abbott istat machine and CG8+ cartridge to determine venous blood gas ionized calcium levels","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.15","spread":"0.02"},{"groupId":"OG001","value":"1.16","spread":"0.03"}]}]}]},{"type":"SECONDARY","title":"Pharmacokinetics of Calcium Chloride - Peak Change in Ionized Calcium From 1 Gram of Calcium Chloride","description":"Generated from a 2-compartment population pharmacokinetic model in NONMEM using serial venous blood gas ionized calcium concentrations.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.39","spread":null}]}]}]},{"type":"SECONDARY","title":"Pharmacodynamic Effect of Calcium Upon Uterine Tone NRS","description":"Data were not collected. This measure required blood specimens to be obtained at the time of tone scores and this was not done.","classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Quantitative Blood Loss, Subgroup Quantitative Blood Loss (QBL, mL), Excluding Cases of Documented Non-atonic Bleeding","description":"Pre-specified subgroup analysis of primary outcome:\n\nBecause the proposed mechanism of calcium action-improving uterine contractility-was not expected to improve bleeding from causes such as hysterotomy extension or arterial bleeding, the trial was powered for a prespecified subgroup analysis excluding patients with nonatonic blood loss documented in the surgeon's operative report. Documented nonatonic bleeding was defined as presence in the surgeon's operative report narrative of any of the following: hysterotomy extension, hysterotomy types other than low transverse (eg classical, T- or J-shaped), invasive or abnormally adherent placenta, placental abruption, uterine rupture, bleeding from leiomyomas, grade 3 or 4 vaginal lacerations, or cervical lacerations.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"759","spread":null},{"groupId":"OG001","value":"922","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":60},"commonTop":["New or subjective worsening in nausea","New or increased vomiting","Change in heart rate","Flushing","Intravenous line pain"]}}}